QUCY
Mainz Biomed N.V.NASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$6.38M
P/E Ratio
—
EPS
$-2.70
Beta
0.47
52W High
$0.94
52W Low
$0.40
50-Day MA
$0.77
200-Day MA
$1.29
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Mainz Biomed N.V.
Mainz Biomed N.V. develops and sells in-vitro diagnostic (IVD) tests for the early detection of cancer in the United States and Europe. The company is headquartered in Mainz, Germany.
Fundamentals
| Revenue (TTM) | 537,080 |
| Gross Profit (TTM) | 389,790 |
| EBITDA | $-12.88M |
| Operating Margin | -2160.00% |
| Return on Equity | -488.30% |
| Return on Assets | -89.60% |
| Revenue/Share (TTM) | $0.09 |
| Book Value | $0.62 |
| Price-to-Book | 9.14 |
| Price-to-Sales (TTM) | 11.88 |
| EV/Revenue | 14.05 |
| EV/EBITDA | -2.83 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -32.90% |
| Shares Outstanding | $12.52M |
| Float | $10.85M |
| % Insiders | 12.62% |
| % Institutions | 9.45% |
Data last updated: 4/9/2026